JNJ

225.85

-0.11%↓

ABT

91.74

-1.11%↓

MDT

83.27

+0.9%↑

120.69

-1.07%↓

VEEV

162.96

-2.86%↓

JNJ

225.85

-0.11%↓

ABT

91.74

-1.11%↓

MDT

83.27

+0.9%↑

120.69

-1.07%↓

VEEV

162.96

-2.86%↓

JNJ

225.85

-0.11%↓

ABT

91.74

-1.11%↓

MDT

83.27

+0.9%↑

120.69

-1.07%↓

VEEV

162.96

-2.86%↓

JNJ

225.85

-0.11%↓

ABT

91.74

-1.11%↓

MDT

83.27

+0.9%↑

120.69

-1.07%↓

VEEV

162.96

-2.86%↓

JNJ

225.85

-0.11%↓

ABT

91.74

-1.11%↓

MDT

83.27

+0.9%↑

120.69

-1.07%↓

VEEV

162.96

-2.86%↓

Strona główna・Stock List・Progyny Inc

Progyny Inc

Closed

SectorHealthcare

17.96 -0.22

Buy Sell

Overview

Share price change

24h

Current

Min

17.46

Max

18.11

Key metrics
By Trading Economics
Income	-1.4M 12M
Sales	5.1M 318M
P/E Sector Avg	28.677 60.328
Profit margin	3.921
Employees	835
EBITDA	-6M 19M

Recommendations
By TipRanks
Recommendations	Buy
12 Months Forecast	+46.67% upside

Dividends
By Dow Jones
Next Earnings	7 maj 2026

Market Stats
By TradingEconomics
Market Cap	-311M 1.5B
Previous open	18.18
Previous close	17.96

News Sentiment

By Acuity

50%

163 / 348 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Strong Bullish Evidence

22.91 / 23.375 Support & Resistance

Progyny Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

23 kwi 2026, 00:00 UTC

Major News Events

Australian Flash PMI Bounce in April Conceals Deeper Worries

22 kwi 2026, 23:33 UTC

Earnings

SK Hynix Posts Record Quarterly Results Amid AI Boom

22 kwi 2026, 22:40 UTC

Earnings

Correction to ServiceNow Posts 22% 1Q Revenue Growth Article

22 kwi 2026, 22:10 UTC

Acquisitions, Mergers, Takeovers

ServiceNow Says $4 Billion Term Loan Credit Deal Will Help Finance Armis Security Deal

22 kwi 2026, 21:11 UTC

Earnings

ServiceNow Posts 22% 1Q Revenue Growth, But Says Armis Deal Will Weigh on Margins

22 kwi 2026, 21:01 UTC

Earnings

IBM Posts Higher 1Q Sales, Buoyed by AI -- Update

22 kwi 2026, 23:46 UTC

Market Talk

Global Equities Roundup: Market Talk

22 kwi 2026, 23:46 UTC

Market Talk

Nikkei May Remain Rangebound; Middle East Conflict in Focus -- Market Talk

22 kwi 2026, 23:34 UTC

Market Talk

Major News Events

Gold Falls as U.S.-Iran Cease-Fire Keeps Inflation Concerns High -- Market Talk

22 kwi 2026, 23:16 UTC

Earnings

SK Hynix: Quarterly Revenue, Profits at All-Time High in 1Q

22 kwi 2026, 23:15 UTC

Earnings

SK Hynix: Operating Profit Margin Reached Record 72% in 1Q

22 kwi 2026, 22:54 UTC

Earnings

SK Hynix 1Q Net Profit Beat FactSet-Compiled Consensus

22 kwi 2026, 22:54 UTC

Earnings

SK Hynix 1Q Net KRW40.346T Vs. Net KRW8.108T >000660.SE

22 kwi 2026, 22:52 UTC

Earnings

SK Hynix 1Q Oper Pft KRW37.610T Vs. Pft KRW7.441T >000660.SE

22 kwi 2026, 22:51 UTC

Earnings

SK Hynix 1Q Rev KRW52.576T Vs. KRW17.639T >000660.SE

22 kwi 2026, 22:31 UTC

Earnings

Sandfire CEO: Delivery Risk, Input Cost Pressure Could Rise Quickly If Situation Deteriorates

22 kwi 2026, 22:31 UTC

Earnings

Sandfire CEO: First, Second Order Impacts of Middle East Conflict Remain Hard to Predict

22 kwi 2026, 22:30 UTC

Earnings

Sandfire CEO: Middle East Conflict Creates Significant Risk in Global Supply Chains

22 kwi 2026, 22:30 UTC

Earnings

Sandfire: FY26 Underlying Operating Unit Costs Expected to 'Materially Aligned' With Guidance

22 kwi 2026, 22:29 UTC

Earnings

Sandfire Resources 3Q Unaudited Underlying Ebitda $220 Million

22 kwi 2026, 22:28 UTC

Earnings

Sandfire Resources 3Q Unaudited Sales Revenue $408 Million

22 kwi 2026, 22:28 UTC

Earnings

Sandfire Resources 3Q Motheo Underlying Operating Unit Cost $44/Ton Ore Processed

22 kwi 2026, 22:27 UTC

Earnings

Sandfire Resources 3Q Matsa Underlying Operating Unit Cost $95/Ton Ore Processed

22 kwi 2026, 22:06 UTC

Market Talk

Earnings

Tesla Paid Robotaxi Miles Nearly Doubled Quarter-Over-Quarter -- Market Talk

22 kwi 2026, 21:55 UTC

Acquisitions, Mergers, Takeovers

ServiceNow Says $4B Term Loan Credit Deal Will Help Finance Armis Security Deal

22 kwi 2026, 21:47 UTC

Earnings

Lam Research Stock Jumps on Strong Earnings -- Barrons.com

22 kwi 2026, 21:37 UTC

Earnings

Texas Instruments Reports Solid Earnings. The Stock Is Up. -- Barrons.com

22 kwi 2026, 21:34 UTC

Earnings

Tesla Surprises Wall Street With Better Profits, $1.4 Billion in Free Cash Flow -- 3rd Update

22 kwi 2026, 21:29 UTC

Earnings

Lam Research Stock Jumps on Strong Earnings -- Barrons.com

22 kwi 2026, 21:20 UTC

Market Talk

Earnings

Tesla Expands Manufacturing to Chips -- Market Talk

Peer Comparison

Price change

Progyny Inc Forecast

Price Target

By TipRanks

46.67% upside

12 Months Forecast

Average 26.43 USD 46.67%

High 31 USD

Low 19 USD

Based on 7 Wall Street analysts offering 12 month price targets forProgyny Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

7 ratings

Buy

Hold

Sell

Based on 7 analysts giving stock ratings to Progyny Inc - Dist in the past 3 months.

Technical Score

By Trading Central

22.91 / 23.375Support & Resistance

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

Sentiment

By Acuity

163 / 348 Ranking in Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Progyny Inc

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.